ES2153030T3 - Procedimiento de analisis cuantitativo del colesterol. - Google Patents

Procedimiento de analisis cuantitativo del colesterol.

Info

Publication number
ES2153030T3
ES2153030T3 ES95913411T ES95913411T ES2153030T3 ES 2153030 T3 ES2153030 T3 ES 2153030T3 ES 95913411 T ES95913411 T ES 95913411T ES 95913411 T ES95913411 T ES 95913411T ES 2153030 T3 ES2153030 T3 ES 2153030T3
Authority
ES
Spain
Prior art keywords
cholesterol
lipoproteins
quantitative analysis
analysis procedure
high density
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95913411T
Other languages
English (en)
Inventor
Koichi Hino
Mitsuhiro Nakamura
Mitsuhisa Manabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Medical Co Ltd
Original Assignee
Daiichi Pure Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11837925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2153030(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Pure Chemicals Co Ltd filed Critical Daiichi Pure Chemicals Co Ltd
Application granted granted Critical
Publication of ES2153030T3 publication Critical patent/ES2153030T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

UN METODO PARA DETERMINAR CUANTITATIVAMENTE COLESTEROL EN LIPOPROTEINAS DE ALTA DENSIDAD, EN EL CUAL, ANTES DE LA DETERMINACION DEL COLESTEROL POR UN METODO ENZIMATICO, SE AÑADE UN SURFACTANTE Y UNA SUBSTANCIA QUE FORMA UN COMPLEJO CON LIPOPROTEINAS DISTINTAS DE LAS LIPOPROTEINAS DE ALTA DENSIDAD A UNA MUESTRA QUE CONTIENE LIPOPROTEINAS. EL METODO NO REQUIERE NINGUN PRETRATAMIENTO COMO LA SEPARACION CENTRIFUGA. CON UNA SIMPLE OPERACION, EL COLESTEROL EN HDLS PUEDE SER MEDIDO EFECTIVAMENTE.TAMBIEN, ESTE METODO PUEDE SER ADOPTADO EN UNA VARIEDAD DE ANALIZADORES AUTOMATICOS, Y POR LO TANTO ES MUY UTIL EN EL CAMPO DE ENSAYOS CLINICOS.
ES95913411T 1995-01-31 1995-04-03 Procedimiento de analisis cuantitativo del colesterol. Expired - Lifetime ES2153030T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7013607A JP2799835B2 (ja) 1995-01-31 1995-01-31 コレステロールの定量方法

Publications (1)

Publication Number Publication Date
ES2153030T3 true ES2153030T3 (es) 2001-02-16

Family

ID=11837925

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95913411T Expired - Lifetime ES2153030T3 (es) 1995-01-31 1995-04-03 Procedimiento de analisis cuantitativo del colesterol.

Country Status (16)

Country Link
US (1) US5773304A (es)
EP (1) EP0753583B1 (es)
JP (1) JP2799835B2 (es)
KR (1) KR100346658B1 (es)
CN (1) CN1072724C (es)
AT (1) ATE197070T1 (es)
AU (1) AU696681B2 (es)
CA (1) CA2185562A1 (es)
DE (1) DE69519160T2 (es)
DK (1) DK0753583T3 (es)
ES (1) ES2153030T3 (es)
GR (1) GR3035274T3 (es)
MX (1) MX9604514A (es)
PT (1) PT753583E (es)
TW (1) TW400385B (es)
WO (1) WO1996023902A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962340A (en) * 1994-11-02 1999-10-05 Wako Pure Chemical Industries Ltd. Homogeneous immunoassay method utilizing 5-300 mM magnesium
ES2165947T3 (es) 1995-07-21 2002-04-01 Wako Pure Chem Ind Ltd Metodo para medir la cantidad de un constituyente contenido en una lipoproteina especifica.
JP3193634B2 (ja) * 1996-05-29 2001-07-30 第一化学薬品株式会社 Ｌｄｌコレステロールの定量方法
ATE304608T1 (de) 1996-12-09 2005-09-15 Denka Seiken Kk Verfahren zur bestimmung des cholesteringehalts von high-density-lipoproteinen
CA2344055C (en) * 1998-09-18 2010-08-17 Kyowa Medex Co., Ltd. Method for fractional determination of cholesterol in lipoproteins and a reagent therefor
US20020188315A1 (en) * 1998-12-31 2002-12-12 Guzman Jose F. Gel tourniquet cuff
EP1148142B1 (en) 1999-01-20 2008-02-27 Kyowa Medex Co., Ltd. Method for quantitating triglyceride in lipoprotein
JP3441993B2 (ja) * 1999-01-27 2003-09-02 松下電器産業株式会社 コレステロールセンサ
CA2366663A1 (en) * 1999-03-24 2000-09-28 Mitsuaki Yamamoto Method for quantitating cholesterol
CN1167809C (zh) 1999-06-21 2004-09-22 第一化学药品株式会社 以游离型胆固醇为底物的酶的反应促进物质
JP3686326B2 (ja) 2000-11-08 2005-08-24 アークレイ株式会社 高密度リポタンパク質（ｈｄｌ）コレステロール測定用試験片
MXPA03004206A (es) 2000-11-14 2003-09-22 Daiichi Pure Chemicals Co Ltd Metodo de ensayo de lipido y reactivo para su uso en el mismo.
US6898728B2 (en) * 2001-09-25 2005-05-24 Sun Microsystems, Inc. System domain targeted, configurable interconnection
ATE384135T1 (de) 2002-01-30 2008-02-15 Denka Seiken Kk Verfahren zur quantifizierung von cholesterin in hd-(high density)-lipoprotein und reagenszusammensetzungen
EP1555326B1 (en) * 2002-10-16 2009-11-25 Kyowa Medex Co., Ltd. Method and reagent for measuring cholesterol in high density lipoproteins
AU2003301324A1 (en) * 2002-10-16 2004-05-04 Kyowa Medex Co., Ltd. Method and reagent for measuring cholesterol in high-density lipoproteins
US20050032141A1 (en) * 2003-07-17 2005-02-10 Dimagno Theodore John Dry analytical element for high-density lipoprotein cholesterol quantification
US7435577B2 (en) * 2004-02-03 2008-10-14 Polymer Technology Systems, Inc. Direct measurement of chlolesterol from low density lipoprotein with test strip
US7625721B2 (en) 2004-02-03 2009-12-01 Polymer Technology Systems, Inc. Non-precipitating bodily fluid analysis system
CN1918303A (zh) * 2004-04-15 2007-02-21 协和梅迪克斯株式会社 高密度脂蛋白中胆甾醇的测定方法
WO2006033733A1 (en) * 2004-08-17 2006-03-30 Polymer Technology Systems, Inc. Bodily fluid analysis system
US20060062690A1 (en) 2004-08-17 2006-03-23 Polymer Technology Systems, Inc. Apparatus and method of manufacturing bodily fluid test strip
US8119360B2 (en) * 2005-02-14 2012-02-21 Kyowa Medex Co., Ltd. Method, reagent and kit for determination of cholesterol in remnant-like particles (RLP)
TWI372783B (en) * 2005-04-27 2012-09-21 Kyowa Medex Co Ltd A process for measuring the cholesterol in high density lipoprotein
CN100365409C (zh) * 2005-06-01 2008-01-30 王贤理 一种测定低密度脂蛋白胆固醇的试剂及制备方法
WO2007007392A1 (ja) 2005-07-11 2007-01-18 Wako Pure Chemical Industries, Ltd. 新規ポリマー及びこれを用いたコレステロール測定法
JP4884012B2 (ja) * 2006-01-25 2012-02-22 シスメックス株式会社 高密度リポタンパク質中コレステロール測定試薬キット及び測定方法
GB0609493D0 (en) * 2006-05-12 2006-06-21 Oxford Biosensors Ltd Cholesterol sensor
GB0609494D0 (en) * 2006-05-12 2006-06-21 Oxford Biosensors Ltd HDL cholesterol sensor using specific surfactant
AU2008261868B2 (en) * 2007-06-08 2014-03-13 Quest Diagnostics Investments Llc Lipoprotein analysis by differential charged-particle mobility
US8247235B2 (en) 2007-06-08 2012-08-21 Quest Diagnostics Investments Incorporated Lipoprotein analysis by differential charged-particle mobility
US9354200B1 (en) 2008-08-07 2016-05-31 Quest Diagnostics Investments Incorporated Detection apparatus for differential-charged particle mobility analyzer
US20120107850A1 (en) * 2009-07-15 2012-05-03 Panasonic Corporation Analysis reagent and analysis device having the analysis reagent carried therein
JP5813284B2 (ja) 2009-10-26 2015-11-17 デンカ生研株式会社 ＡｐｏＥ−ｃｏｎｔａｉｎｉｎｇＨＤＬ中コレステロールの測定方法
WO2012011563A1 (ja) * 2010-07-23 2012-01-26 デンカ生研株式会社 高密度リポタンパク質３中のコレステロールの定量方法
JP5671029B2 (ja) * 2010-07-23 2015-02-18 デンカ生研株式会社 高密度リポタンパク質３中のコレステロールの定量方法
US9250211B2 (en) 2010-12-30 2016-02-02 Quest Diagnostics Investments Incorporated Magnetic separation of lipoproteins using dextran sulfate
US9080201B2 (en) 2011-03-16 2015-07-14 Kyowa Medex Co., Ltd. Method for measuring cholesterol in HDL subfraction, and reagents and kit therefor
CN110042146B (zh) 2011-11-11 2023-09-01 雅培快速诊断国际无限公司 血样本的化验方法
JP6054051B2 (ja) 2012-04-11 2016-12-27 デンカ生研株式会社 高密度リポ蛋白（ｈｄｌ）中のコレステロール（−ｃ）の亜分画定量方法
EP2891718B1 (en) 2012-08-31 2019-01-30 Kyowa Medex Co., Ltd. Method for measuring cholesterol in high-density lipoprotein
ES2765475T3 (es) * 2014-08-12 2020-06-09 Shino Test Corp Proceso de producción de una solución de sustrato para medir la actividad lipasa y método de simplificación de la producción
CN105137099A (zh) * 2015-09-08 2015-12-09 长春理工大学 一种用次血红素六肽测定血清总胆固醇方法
CN120118970A (zh) * 2023-12-08 2025-06-10 南京晶捷生物科技有限公司 总胆固醇检测复合酶液、检测试纸和检测系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2128670B2 (de) * 1971-06-09 1977-06-30 Merck Patent Gmbh, 6100 Darmstadt Immunologische isoenzym-bestimmungsmethode
CH582884A5 (es) * 1973-12-10 1976-12-15 Hoffmann La Roche
US4226713A (en) * 1978-04-24 1980-10-07 Goldberg Jack M Diagnostic agents
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
US4210557A (en) * 1978-12-15 1980-07-01 Beckman Instruments, Inc. Non-high density lipoprotein precipitant
FR2513766B1 (fr) * 1981-09-28 1985-09-13 Biomerieux Sa Procedes et reactifs de separation selective des lipoproteines de faible densite ldl et de quantification de leurs composants
US4946796A (en) * 1982-01-05 1990-08-07 International Institute Of Cellular & Molecular Pathology Method of immunoassay
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
EP0229767B1 (en) * 1985-03-18 1990-09-26 Royal Free Hospital School Of Medicine Improvements relating to the detection of viruses and antibodies
JPS6242110A (ja) * 1985-08-20 1987-02-24 Fujitsu Ltd 露光装置
DE3636851A1 (de) * 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
US5215886A (en) * 1987-06-22 1993-06-01 Patel P Jivan HDL determination in whole blood
US4900662A (en) * 1987-07-21 1990-02-13 International Immunoassay Laboratories, Inc. CK-MM myocardial infarction immunoassay
US5030555A (en) * 1988-09-12 1991-07-09 University Of Florida Membrane-strip reagent serodiagnostic apparatus and method
DE3929032C2 (de) * 1989-09-01 1998-09-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von HDL-Cholesterin mittels eines Schnelldiagnostikums mit integriertem Fraktionierschritt
US5403745A (en) * 1990-04-27 1995-04-04 Genzyme Corporation Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
US5286626A (en) * 1991-12-13 1994-02-15 Actimed Laboratories, Inc. Process and apparatus for direct determination of low density lipoprotein
JP3107474B2 (ja) * 1993-02-17 2000-11-06 国際試薬株式会社 リポ蛋白分画中の成分の定量方法

Also Published As

Publication number Publication date
US5773304A (en) 1998-06-30
DE69519160T2 (de) 2001-05-17
EP0753583A4 (en) 1997-12-10
JPH08201393A (ja) 1996-08-09
KR100346658B1 (ko) 2002-11-23
DK0753583T3 (da) 2000-11-13
ATE197070T1 (de) 2000-11-15
CA2185562A1 (en) 1996-08-08
AU2085295A (en) 1996-08-21
MX9604514A (es) 1997-12-31
WO1996023902A1 (en) 1996-08-08
DE69519160D1 (de) 2000-11-23
EP0753583A1 (en) 1997-01-15
AU696681B2 (en) 1998-09-17
TW400385B (en) 2000-08-01
EP0753583B1 (en) 2000-10-18
PT753583E (pt) 2001-03-30
KR970701789A (ko) 1997-04-12
CN1145096A (zh) 1997-03-12
JP2799835B2 (ja) 1998-09-21
GR3035274T3 (en) 2001-04-30
CN1072724C (zh) 2001-10-10

Similar Documents

Publication Publication Date Title
GR3035274T3 (en) Method of quantitative analysis of cholesterol
IL94087A0 (en) Methods,reagents and test kits for determining the presence or quantitiy of biological components in an analyzed sample
SE8008952L (sv) Forfarande och anordning for bestemning av serumlipoproteiner
Guder et al. The Haemolytic, Icteric and Lipemic Sample-Recommendations Regarding their Recognition and Prevention of Clinically Relevant Interferences
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
WO2003001964A3 (en) Measurement testing of blood specimens
CA2634654A1 (en) Reagent compositions for analytical testing
DE69324763D1 (de) Vorrichtung und Verfahren zur Analyse von HDL-Cholesterin in Vollblut
JPS57114859A (en) Analysis and measurement with centrifugal analyzer and rotor insertion element suitable therefor
IL117862A (en) Method and composition for counting white blood cells
RU94038061A (ru) Способ определения гомоцистеина в пробе и набор для его осуществления
DK314987D0 (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
NO963477L (no) Analysekuvette, fremgangsmåte samt diagnostisk sett for bestemmelse av analytter i fullblod-pröver
DK0922229T3 (da) Fremgangsmåde til kontinuerlig eller diskontinuerlig automatisk analyse af pröver indeholdt i beholdere
ATE107418T1 (de) Nachweis von analyt in partikel enthaltenden proben.
ATE206746T1 (de) Reinigungslösung für analysegerät
Wang et al. The stability of human blood lead in storage
EP1164376A4 (en) METHOD FOR QUANTIFYING CHOLESTERIN
Sharma et al. The turbid specimen as an analytical medium: hemoglobin determination as a model
ATE520034T1 (de) Quantitative analyse einer biologischen probe unbekannter menge
Palekar et al. Quantitative analysis for detection of cholesterol using colorimetric platform
Shaikh et al. Validation and comparison; a step towards the automation for measuring the erythrocyte sedimentation rate
Furuwatari et al. Clinical evaluation of RT-PCR method for detection of HCV-RNA: second report availability of RT-PCR system using PCR internal control for detection of HCV-RNA and the influence of interfering substances on the detection
WO2004016802A3 (en) Methods and apparatus for preparing and assaying biological samples to determine protein concentration
DE69033072D1 (de) Verfahren und Mittel zum Nachweis von Krankheitszuständen aus Änderungen im Östrogenstoffwechsel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 753583

Country of ref document: ES